LRRC47: A Multi-Functional Protein with Potential as A Cancer Target

Target Name: LRRC47

NCBI ID: G57470

LRRC47

LRRC47: A Multi-Functional Protein with Potential as A Cancer Target

LRRC47 (KIAA1185) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a member of the long non-coding RNA (lncRNA) family, which includes proteins that have been implicated in a wide range of biological processes. One of the most significant functions of LRRC47 is its role in cell signaling, specifically in the regulation of the immune response and inflammation.

The immune response is a crucial aspect of maintaining the health and well-being of the body, and LRRC47 plays a critical role in this process. LRRC47 has been shown to regulate the production and function of natural killer cells, which are a crucial part of the immune system that are responsible for detecting and destroying abnormal cells in the body. In addition, LRRC47 has also been shown to regulate the activation and proliferation of T cells, which are another important part of the immune system.

LRRC47 has also been shown to play a key role in the regulation of inflammation. Chronic inflammation can contribute to a wide range of diseases, including heart disease, cancer, and autoimmune disorders. LRRC47 has been shown to regulate the production of pro-inflammatory cytokines, which are important drivers of inflammation. In addition, LRRC47 has also been shown to regulate the functions of immune cells, including the production and activation of T cells, which are involved in the regulation of inflammation.

LRRC47 is also known as KIAA1185, which is a gene that encodes a protein with multiple potential drug targets. One of the most promising potential drug targets for LRRC47 is its role in the regulation of cancer. LRRC47 has been shown to be involved in the regulation of cell cycle progression, which is a critical aspect of cancer development. In addition, LRRC47 has also been shown to be involved in the regulation of apoptosis, which is the process by which cells undergo programmed cell death.

LRRC47 has also been shown to be involved in the regulation of stem cell maintenance and proliferation. Stem cells are a crucial part of the immune system, and they have the potential to develop into fully-functional tissues or organs. LRRC47 has been shown to be involved in the regulation of stem cell proliferation and differentiation, which are critical processes for the development and maintenance of stem cells.

In addition to its role in cell signaling and immune function, LRRC47 has also been shown to have a wide range of other biological functions. For example, LRRC47 has been shown to play a key role in the regulation of cellular adhesion, which is the process by which cells stick together to form tissues and organs. In addition, LRRC47 has also been shown to be involved in the regulation of cell signaling pathways, including the regulation of DNA replication and the detoxification of environmental toxins.

Overall, LRRC47 is a protein that has a wide range of biological functions, including its role in cell signaling and immune function, and its involvement in the regulation of cancer, stem cell maintenance and proliferation. As a result, LRRC47 is a promising target for drug development, and further research is needed to fully understand its functions and potential as a drug.

Protein Name: Leucine Rich Repeat Containing 47

The "LRRC47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets